MyCTC chip: microfluidic-based drug screen with patient-derived tumour cells from liquid biopsies
Fabienne D. Schwab(University of Basel), Nicola Aceto(ETH Zurich)
Cited by 23
Related Papers
Digoxin for reduction of circulating tumor cell cluster size in metastatic breast cancer: a proof-of-concept trial
|Nature Medicine|2025|49
Taurolidine and oxidative stress: a rationale for local treatment of mesothelioma
|European Respiratory Journal|2009|26